2014
DOI: 10.1158/1055-9965.epi-13-0865
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases

Abstract: Background Hodgkin Lymphoma (HL) is uncommon in the U.S. general population; however, HL risk is elevated in people with human immunodeficiency virus (HIV) infection. Thus, despite the low HIV prevalence in the U.S, the HIV epidemic may have contributed substantially to the general population burden of HL. Methods We used data from 14 U.S. cancer registries in the Surveillance, Epidemiology and End Results Program that recorded HIV status of HL cases at diagnosis during 2000–2010. We computed the HIV prevale… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
53
1
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 62 publications
(57 citation statements)
references
References 23 publications
(28 reference statements)
1
53
1
2
Order By: Relevance
“…Excisional biopsy revealed recurrent EBV-positive (EBV 1 ) cHL lymphoma, MC subtype. CD4 1 count was 145 cells per mm 3 and HIV viral load remained undetectable. 18 FDG-PET revealed no extranodal disease ( Figure 2D).…”
Section: Medscape Continuing Medical Education Onlinementioning
confidence: 92%
See 4 more Smart Citations
“…Excisional biopsy revealed recurrent EBV-positive (EBV 1 ) cHL lymphoma, MC subtype. CD4 1 count was 145 cells per mm 3 and HIV viral load remained undetectable. 18 FDG-PET revealed no extranodal disease ( Figure 2D).…”
Section: Medscape Continuing Medical Education Onlinementioning
confidence: 92%
“…After 2 cycles, CT showed no disease, and he proceeded to autologous stem cell transplant (auto-SCT) following carmustine, etoposide, cytarabine, and melphalan conditioning. CD4 1 count 3 months posttransplant was 186 cells per mm 3 . The patient has been followed on cART for 7 years with no relapse, undetectable HIV with CD4…”
Section: Medscape Continuing Medical Education Onlinementioning
confidence: 96%
See 3 more Smart Citations